Anselme Limited Launches Cash Offer to Acquire All Shares of Huakang Biomedical Holdings

Anselme Limited has launched an offer to acquire all issued shares of Huakang Biomedical Holdings Company Limited that it does not already own or has agreed to acquire, as well as to cancel all outstanding share options of the company. The move follows a sale and purchase agreement signed on October 9, 2025, under which Anselme Limited agreed to purchase shares from the vendor, with completion occurring immediately upon signing. Details of the offer, including terms and responses from the company’s board and an independent board committee, have been set out in a composite document provided to shareholders and optionholders. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Huakang Biomedical Holdings Co. Ltd. published the original content used to generate this news brief on November 20, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here